Last updated: May 17, 2026
Zembrace SymTouch suppliers: who manufactures and supplies sumatriptan for injection (FDA label, sourcing map, and contractor network)
Executive summary: Zembrace SymTouch is a branded, prescription injectable product containing sumatriptan (sumatriptan succinate). Supplier visibility in the public record is driven by FDA labeling (manufacturer/supplier lines), Orange Book listing (if applicable), and contract manufacturing disclosures in FDA inspection records and label-printed sites. Public label records show the product is tied to specific manufacturing/marketing entities and their manufacturing facilities.
No further supplier mapping can be produced without verifiable source lines tied to current label manufacturer, repackager/distributor, and contract manufacturing sites.
Who are the Zembrace SymTouch suppliers listed on the FDA label?
Featured snippet answer: The FDA-approved label identifies the product’s manufacturer and often the packaged by/marketed by entity. These label lines are the highest-confidence “supplier” definition for licensing, procurement, and litigation discovery.
What names appear as “Manufactured for” or “Distributed by”
Zembrace SymTouch supplier entities typically show up on the prescribing information under sections that list the manufacturer/marketer and the contact corporate address. In practice, these can differ from the actual sterile fill-finish site if the brand uses contract manufacturing.
Which facilities can be suppliers versus label marketers
For injectable sumatriptan, supplier roles break down into:
- Label marketer / sponsor: the legal entity responsible for FDA compliance and commercialization.
- Manufacturer of record: signs the manufacturing statement and controls the product release testing system.
- Contract manufacturing site (sterile drug product): sterile manufacturing and fill-finish under a quality system.
- Packaging supplier (device/pen/autoinjector components): relevant when the device is integrated into the final presentation.
- Packaging and labeling vendor: prints and applies label and device components.
A complete supplier network requires label-printed entity names tied to each role.
Which companies make and fill-finish Zembrace SymTouch (sterile manufacturing)
Featured snippet answer: Zembrace SymTouch is a sterile injectable. The “maker” for supply-chain purposes is the entity tied to the sterile manufacturing and batch release system, not only the brand sponsor.
Sterile fill-finish supply chain
Common sterile injector supply-chain components include:
- Aseptic drug product manufacture (solution preparation and sterile filtration).
- Aseptic fill into the primary container.
- Terminal integration with the delivery system (when the product is packaged in an autoinjector/pen format).
- Labeling and distribution packaging.
Why fill-finish suppliers matter for procurement
Procurement teams care whether the same site supplies:
- US launches and ongoing production
- device-integrated presentations
- strength/dose variants
- shortages and allocation plans
A supplier network with facility IDs must be sourced from label facility statements and verified inspection records.
What generic or authorized supplier ecosystem supports Zembrace SymTouch supply
Featured snippet answer: Zembrace SymTouch’s supply is brand-controlled for the labeled product; generics typically do not supply Zembrace SymTouch itself. The “ecosystem” refers to upstream API and sterile drug product manufacturing capabilities, not direct replacement branding.
Sumatriptan injection upstream suppliers
Upstream suppliers usually split into:
- API suppliers for sumatriptan succinate
- sterile drug product manufacturers that can produce injectable sumatriptan
- device component suppliers (if packaged in an autoinjector)
Without verified sources mapping Zembrace-specific API and sterile fill suppliers, listing named companies would be speculative.
How does the Zembrace SymTouch supply chain affect shortages and allocation risk?
Featured snippet answer: Shortage risk tracks to sterile manufacturing capacity, device packaging constraints, and batch release/testing bandwidth at the manufacturer of record.
Allocation triggers for injectable, device-integrated products
For branded sterile injections, shortages commonly occur when:
- Sterile fill-finish capacity is constrained
- Sterility assurance systems require extended hold times
- Device integration requires additional packaging line validation
- Batch rejection rates increase during process changes
These triggers are operational; actionable supplier risk assessment requires the named manufacturer facility and any publicly recorded inspection or recall actions.
What is the Orange Book status of Zembrace SymTouch and how does it impact sourcing?
Featured snippet answer: Orange Book status can support whether the product has listed patents tied to formulation, method-of-use, or device/injection presentation. That can affect manufacturing licensing, but it does not identify the sterile fill supplier.
What Orange Book listings can and cannot tell you
Orange Book listings can help identify:
- branded product and strength(s)
- patent numbers and expiration windows
- whether there are AB-rated generics
Orange Book listings do not reliably name contract manufacturers or API vendors for procurement.
Which suppliers support Zembrace SymTouch manufacturing outside the US?
Featured snippet answer: For US-labeled sterile injectables, international manufacturing matters only if the label identifies the manufacturing site or if FDA inspection records tie the site to the marketed product.
Cross-border supply chain constraints
Key constraints include:
- sterile manufacturing compliance with cGMP
- importation under the US manufacturer of record
- device component sourcing and documentation
A verified supplier-to-site mapping is required to answer this with factual company names.
Key Takeaways
- Zembrace SymTouch is a branded sumatriptan sterile injectable product.
- The most defensible “suppliers” in pharma procurement and litigation are the entities named in FDA-approved labeling as manufacturer/packager/distributor.
- A complete supplier network (sterile fill-finish, packaging, API upstream, device components) requires label-verified entity and facility statements tied to the marketed product.
FAQs
- Is the Zembrace SymTouch manufacturer the same as the brand sponsor?
- Which entity on the label is most relevant for batch release questions?
- Do Orange Book listings identify the contract manufacturing site for Zembrace SymTouch?
- How do device packaging constraints influence supply for Zembrace SymTouch?
- Are API suppliers for sumatriptan injection the same across brand and generic products?
References
- U.S. Food and Drug Administration. Prescribing Information for ZEMBRACE SYMTOUCH (sumatriptan succinate injection).
